Works about COMBINATION drug therapy


Results: 5000
    1
    3
    4
    5
    6
    7
    8
    9

    Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study.

    Published in:
    Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 6, p. 1005, doi. 10.1111/head.14871
    By:
    • Ailani, Jessica;
    • Lipton, Richard B.;
    • Blumenfeld, Andrew M.;
    • Mechtler, Laszlo;
    • Klein, Brad C.;
    • He, Molly Yizeng;
    • Smith, Jonathan H.;
    • Trugman, Joel M.;
    • de Abreu Ferreira, Rosa;
    • Brand‐Schieber, Elimor
    Publication type:
    Article
    10
    11
    12
    13
    14

    Teneligliptin-Induced Polyarthritis: A Case Report.

    Published in:
    Journal of Diabetology: Official Journal of Diabetes in Asia Study Group, 2021, v. 12, n. 4, p. 528, doi. 10.4103/jod.jod_23_21
    By:
    • Agrawal, Prabhat Kumar;
    • Pursnani, Nikhil;
    • Gautam, Ashish;
    • Singh, Boentika;
    • Yadav, Asvini
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Sulopenem Etzadroxil/Probenecid.

    Published in:
    Hospital Pharmacy, 2025, v. 60, n. 4, p. 331, doi. 10.1177/00185787251324844
    By:
    • Baker, Danial E.;
    • Levien, Terri L.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Comparative effectiveness of extended‐release naltrexone versus buprenorphine‐naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population‐based observational data

    Published in:
    Addiction, 2025, v. 120, n. 8, p. 1634, doi. 10.1111/add.70040
    By:
    • Lodi, Sara;
    • Yan, Shapei;
    • Bovell‐Ammon, Benjamin;
    • Christine, Paul J.;
    • Hsu, Heather E.;
    • Bernson, Dana;
    • Novo, Patricia;
    • Lee, Joshua D.;
    • Rotrosen, John;
    • Liebschutz, Jane M.;
    • Walley, Alexander Y.;
    • Larochelle, Marc R.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma.

    Published in:
    Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf138
    By:
    • Beckermann, Kathryn E;
    • Shah, Neil J;
    • Campbell, Matthew T;
    • Haas, Naomi B;
    • Nelson, Ariel;
    • Ornstein, Moshe C;
    • Mao, Shifeng;
    • Keshava-Prasad, Holavanahalli S;
    • Hammers, Hans;
    • Gao, Xin;
    • Gourdin, Theodore;
    • George, Saby;
    • Hoimes, Christopher J;
    • Hussain, Arif;
    • Jonasch, Eric;
    • Rini, Brian I;
    • Voss, Martin H
    Publication type:
    Article
    47
    48
    49
    50